SWOG clinical trial number
SWOG-8040
Evaluation of Combination Chemotherapy (FAM-S) vs. a Phase II Drug in Pancreatic Adenocarcinoma
Closed
Published
Abbreviated Title
Evaluation of Combination Chemotherapy (FAM-S) vs. a Phase II Drug in Pancreatic Adenocarcinoma
Activated
01/28/1981
Closed
03/16/1984
Publication Information Expand/Collapse
1993
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma: A Southwest Oncology Group Study.
1985
Randomized trials of combination chemotherapy vs. a Phase II drug in metastatic adenocarcinoma of the pancreas: Southwest Oncology Group study.
1984
Characteristics of long term survivors receiving chemotherapy for pancreatic adenocarcinoma in Southwest Oncology Group (SWOG) studies.